Search research articles
Contact Us
Filters
Showing results (251-260 of 523) with videos related to
Page
of 53
Sort By:
Cancers
|
April 17, 2019
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer
Jessica M Konen, B Leticia Rodriguez, Jared J Fradette, et al.
Oncogene
|
October 25, 2016
Multiplatform-based molecular subtypes of non-small-cell lung cancer
F Chen, Y Zhang, E Parra, et al.
The Journal of Infection
|
September 28, 2020
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals
Ronald A Seaton, Cheryl L Gibbons, Lesley Cooper, et al.
Science Advances
|
June 19, 2021
p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi
Xiaochao Tan, Priyam Banerjee, Lei Shi, et al.
The Journal of Clinical Investigation
|
September 15, 2020
A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma
Xiaochao Tan, Lei Shi, Priyam Banerjee, et al.
The Journal of Clinical Investigation
|
March 16, 2011
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice
Yanan Yang, Young-Ho Ahn, Don L Gibbons, et al.
Nature Communications
|
July 13, 2026
Epigenetic signatures mark early peripheral human B lineage bifurcation and differential transcriptional profiles in mature populations
Chiara Dionisi, Audrey Kelly, Michael J Pitcher, et al.
BMC Public Health
|
February 13, 2014
Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods
Cheryl L Gibbons, Marie-Josée J Mangen, Dietrich Plass, et al.
Molecular and Cellular Biology
|
September 8, 2011
Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression
Young-Ho Ahn, Yanan Yang, Don L Gibbons, et al.
The Journal of Clinical Investigation
|
August 2, 2012
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
Young-Ho Ahn, Don L Gibbons, Deepavali Chakravarti, et al.
Page
of 53
Search research articles
Search
Showing results (251-260 of 523) with videos related to
Sort By:
Page
of 53
Cancers
|
April 17, 2019
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer
Jessica M Konen, B Leticia Rodriguez, Jared J Fradette, et al.
Oncogene
|
October 25, 2016
Multiplatform-based molecular subtypes of non-small-cell lung cancer
F Chen, Y Zhang, E Parra, et al.
The Journal of Infection
|
September 28, 2020
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals
Ronald A Seaton, Cheryl L Gibbons, Lesley Cooper, et al.
Science Advances
|
June 19, 2021
p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi
Xiaochao Tan, Priyam Banerjee, Lei Shi, et al.
The Journal of Clinical Investigation
|
September 15, 2020
A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma
Xiaochao Tan, Lei Shi, Priyam Banerjee, et al.
The Journal of Clinical Investigation
|
March 16, 2011
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice
Yanan Yang, Young-Ho Ahn, Don L Gibbons, et al.
Nature Communications
|
July 13, 2026
Epigenetic signatures mark early peripheral human B lineage bifurcation and differential transcriptional profiles in mature populations
Chiara Dionisi, Audrey Kelly, Michael J Pitcher, et al.
BMC Public Health
|
February 13, 2014
Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods
Cheryl L Gibbons, Marie-Josée J Mangen, Dietrich Plass, et al.
Molecular and Cellular Biology
|
September 8, 2011
Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression
Young-Ho Ahn, Yanan Yang, Don L Gibbons, et al.
The Journal of Clinical Investigation
|
August 2, 2012
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
Young-Ho Ahn, Don L Gibbons, Deepavali Chakravarti, et al.
Page
of 53